azd8154
Small moleculeexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jul 26, 2018 (NCT03436316)
Timeline
Indications
Studied for
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04480879 | Phase 1 | Jul 17, 2020 | AstraZeneca, Parexel |
| NCT04187508 | Phase 2 | Jan 20, 2020 | AstraZeneca, Parexel |
| NCT03436316 | Phase 1 | Jul 26, 2018 | AstraZeneca, Parexel |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| AstraZeneca | For profit | 3 | 3 | 2 | 2018 |
| Parexel | For profit | 3 | 0 | 2 | 2018 |
2 organizations
Page 1 / 1